Ambalal Sarabhai Enterprises Limited (BOM:500009)
26.07
-0.02 (-0.08%)
At close: Jan 22, 2026
BOM:500009 Revenue
Ambalal Sarabhai Enterprises had revenue of 444.49M INR in the quarter ending September 30, 2025, a decrease of -0.57%. This brings the company's revenue in the last twelve months to 1.97B, up 7.14% year-over-year. In the fiscal year ending March 31, 2025, Ambalal Sarabhai Enterprises had annual revenue of 1.97B with 13.20% growth.
Revenue (ttm)
1.97B
Revenue Growth
+7.14%
P/S Ratio
1.02
Revenue / Employee
3.60M
Employees
547
Market Cap
2.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.97B | 230.03M | 13.20% |
| Mar 31, 2024 | 1.74B | 32.87M | 1.92% |
| Mar 31, 2023 | 1.71B | -266.02M | -13.46% |
| Mar 31, 2022 | 1.98B | 324.75M | 19.66% |
| Mar 31, 2021 | 1.65B | 316.72M | 23.72% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.57B |
| Sat Kartar Shopping | 1.63B |
| Gennex Laboratories | 1.49B |
| Astonea Labs | 1.17B |
| Oxygenta Pharmaceutical | 1.12B |
| Aayush Wellness | 1.11B |
| Quest Laboratories | 1.10B |
| Coral Laboratories | 889.77M |